InsidersTradesSigma
GoHealth, Inc. Stock: price and management transactions · United States · SEC (Form 4)
Follow the GoHealth, Inc. share price and the full management transaction log of the company, a publicly traded company based in United States. Shares trade on US US, under the supervision of SEC (Form 4). Operating in the Healthcare & Pharma sector, GoHealth, Inc. has logged 121 reports. Market capitalisation: €25.1m. The latest transaction was disclosed on 7 May 2025 (Retenue fiscale). Among the most active insiders: CCP III Cayman GP Ltd.. Every trade is accessible without an account.
121
Insider Decl.
0
Thresholds
€19m
46 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate GoHealth, Inc. Buy (bullish), based on 4 analysts. Average price target: US$5.13.
32Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 7 May 2025
Declarations121 total
24,612 shares@ US$10.1726.6% of flowClass A Common StockSEC:0001808220-25-000039:0
500,000 shares0Class A Common StockSEC:0001808220-25-000035:0
100,000 shares0Class A Common StockSEC:0001808220-25-000026:0
8,317 shares@ US$12.3931.1% of flowClass A Common StockSEC:0001808220-25-000028:0
24,611 shares@ US$12.3933.8% of flowClass A Common StockSEC:0001808220-25-000032:0
6,238 shares@ US$13.0024.3% of flowClass A Common StockSEC:0001808220-25-000019:0
150,000 shares0Class A Common StockSEC:0001808220-24-000122:0
5,545 shares@ US$8.2813.5% of flowClass A Common StockSEC:0001808220-24-000110:0
4,159 shares@ US$9.0811.3% of flowClass A Common StockSEC:0001808220-24-000105:0
14,605 shares@ US$10.2749.9% of flowClass A Common StockSEC:0001808220-24-000087:0
9,906 shares@ US$13.98100.0% of flowClass A Common StockSEC:0001808220-24-000092:0
14,605 shares@ US$10.2749.9% of flowClass A Common StockSEC:0001808220-24-000091:0
24,342 shares@ US$10.2749.9% of flowClass A Common StockSEC:0001808220-24-000089:0
25,000 shares0Class A Common StockSEC:0001808220-24-000063:0
16,278 shares@ US$9.6017.4% of flowClass A Common StockSEC:0001808220-24-000038:0
3,145 shares@ US$9.6023.7% of flowClass A Common StockSEC:0001808220-24-000040:0
33,333 shares0Class A Common StockSEC:0001808220-24-000036:0
100,000 shares0Class A Common StockSEC:0001808220-24-000032:0
166,666 shares0Class A Common StockSEC:0001808220-24-000034:0
25 of 121 declarations
About GoHealth, Inc.
GoHealth, Inc. (ticker: GOCO) is a U.S.-listed company trading on the NASDAQ in the United States. For international investors, GoHealth is best understood as a healthcare distribution and insurance marketplace platform with a strong Medicare focus. The company was founded in 2001 by Clint Jones and Brandon Cruz, initially as a comparison site for insurance carriers. Over time, it expanded into lead generation, enrollment, and consumer matching capabilities, evolving into an integrated digital insurance marketplace. GoHealth’s corporate headquarters are in Chicago, Illinois. The company’s core business centers on a proprietary technology platform that combines machine-learning algorithms, more than two decades of insurance purchasing behavior, and licensed human agents. This hybrid model is designed to help consumers find health plans that fit their individual needs, particularly within Medicare. GoHealth positions itself as a consumer-first marketplace, emphasizing plan suitability, enrollment quality, and renewal economics rather than a purely transactional sales model. Historically, the company was also active in Affordable Care Act enrollment, but its strategic center of gravity has shifted toward Medicare in recent years. From a competitive standpoint, GoHealth operates in a fragmented but highly competitive environment that includes insurance brokers, digital enrollment platforms, lead-generation businesses, and insurers with their own distribution channels. Its relative advantage lies in the combination of proprietary technology, licensed sales support, and the ability to process large enrollment volumes. Management continues to focus on improving conversion efficiency, strengthening back-book economics, and refining consumer matching. The company does not pay dividends and instead reinvests in its technology stack, licensed agent force, and the Encompass platform. Recent developments suggest a company in strategic transition. In its latest disclosures and earnings communications, GoHealth has emphasized cash discipline, portfolio durability, and a more selective stance on Medicare Advantage, while maintaining leadership in Special Needs Plans (SNP). A notable strategic step was the 2025 launch of GoHealth Protect, an expansion beyond Medicare-related products into life insurance designed to address end-of-life and broader financial protection needs. The company is also investing in AI and operational efficiency, while management has indicated that consolidation opportunities remain part of its long-term strategic framework in a still-fragmented industry.
